Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing mifepristone plus misoprostol to misoprostol alone for mid-trimester abortion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Abortion, Induced | Phase 3 | Status: TERMINATED